Department of Ophthalmology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Am J Ophthalmol. 2019 Nov;207:184-194. doi: 10.1016/j.ajo.2019.05.030. Epub 2019 Jun 10.
To compare the long-term efficacy and safety of 2 operation methods for late in-the-bag intraocular lens (IOL) dislocation.
Prospective, randomized, parallel group surgical clinical trial.
During a 3-year period, 104 patients (104 eyes) were assigned one group for IOL repositioning by scleral suturing (n = 54) or one group for IOL exchange by retropupillary fixation of an iris claw IOL (n = 50). A single surgeon performed all operations using an anterior approach. Patients were examined before surgery and at 6 months and 1 and 2 years after surgery. The present study included the 66 patients (63%) who completed the 2-year follow-up, and the main outcaome measurement was corrected distance visual acuity (CDVA) 2 years after surgery.
After 2 years, the mean CDVA was 0.20 ± 0.29 logarithm of the minimum angle of resolution (logMAR) units (range, -0.18 to 1.10) in the repositioning group and 0.22 ± 0.30 logMAR (range, -0.10 to 1.22) in the exchange group (P = .69). A CDVA of 20/40 or better was achieved by 76% of all patients. Four eyes (12%) had cystoid macular edema in the repositioning group compared with 5 eyes (15%) in the exchange group. Two eyes underwent redislocation (1 in each group). There were no cases of endophthalmitis or retinal detachment.
There were no significant differences between the visual acuity using IOL repositioning and that using IOL exchange 2 years after surgery. The two methods were equally efficient and safe from a long-term perspective and are both considered acceptable treatments.
比较两种手术方法治疗后囊内人工晶状体(IOL)脱位的长期疗效和安全性。
前瞻性、随机、平行分组手术临床研究。
在 3 年期间,将 104 例(104 只眼)患者分为两组,一组通过巩膜缝线进行 IOL 复位(n=54),另一组通过后房型虹膜抓钩 IOL 进行 IOL 置换(n=50)。由同一位外科医生使用前房入路完成所有手术。患者在术前以及术后 6 个月、1 年和 2 年进行检查。本研究包括完成 2 年随访的 66 例患者(63%),主要观察指标为术后 2 年时的矫正视力(CDVA)。
2 年后,复位组的平均 CDVA 为 0.20±0.29 最小分辨角对数(logMAR)单位(范围:-0.18 至 1.10),置换组为 0.22±0.30 logMAR(范围:-0.10 至 1.22)(P=0.69)。所有患者中有 76%的视力达到 20/40 或更好。复位组有 4 只眼(12%)发生囊样黄斑水肿,置换组有 5 只眼(15%)(P=0.69)。两组各有 1 只眼发生再次脱位。均无眼内炎或视网膜脱离发生。
术后 2 年时,IOL 复位和 IOL 置换的视力无显著差异。从长期来看,两种方法的效果和安全性相当,均可作为可接受的治疗方法。